Consonance Capital Management LP Macrogenics Inc Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$20.49 - $35.63 $50.7 Million - $88.1 Million
-2,472,447 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$18.99 - $33.2 $3.28 Million - $5.73 Million
172,618 Added 7.51%
2,472,447 $78.7 Million
Q4 2020

Feb 16, 2021
SELL
$19.41 - $26.0 $28.1 Million - $37.6 Million
-1,447,469 Reduced 38.63%
2,299,829 $52.6 Million
Q3 2020

Nov 16, 2020
SELL
$24.69 - $31.6 $7.26 Million - $9.3 Million
-294,237 Reduced 7.28%
3,747,298 $94.4 Million
Q2 2020

Aug 14, 2020
BUY
$5.2 - $29.12 $21 Million - $118 Million
4,041,535 New
4,041,535 $113 Million

Others Institutions Holding MGNX

# of Institutions
132
Shares Held
55.4M
Call Options Held
215K
Put Options Held
238K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email